BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 19132220)

  • 1. Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells.
    Samarakoon R; Higgins PJ
    Thromb Haemost; 2008 Dec; 100(6):976-83. PubMed ID: 19132220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.
    Samarakoon R; Higgins SP; Higgins CE; Higgins PJ
    J Mol Cell Cardiol; 2008 Mar; 44(3):527-38. PubMed ID: 18255094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling.
    Kutz SM; Higgins CE; Samarakoon R; Higgins SP; Allen RR; Qi L; Higgins PJ
    Exp Cell Res; 2006 Apr; 312(7):1093-105. PubMed ID: 16457817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-induced Src kinase and caveolin-1 signaling in TGF-β1-initiated SMAD2/3 activation and PAI-1 expression.
    Samarakoon R; Chitnis SS; Higgins SP; Higgins CE; Krepinsky JC; Higgins PJ
    PLoS One; 2011; 6(7):e22896. PubMed ID: 21829547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
    Allen RR; Qi L; Higgins PJ
    J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1.
    Samarakoon R; Higgins SP; Higgins CE; Higgins PJ
    Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31382626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEK/ERK pathway mediates cell-shape-dependent plasminogen activator inhibitor type 1 gene expression upon drug-induced disruption of the microfilament and microtubule networks.
    Samarakoon R; Higgins PJ
    J Cell Sci; 2002 Aug; 115(Pt 15):3093-103. PubMed ID: 12118065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential requirement for MEK/ERK and SMAD signaling in PAI-1 and CTGF expression in response to microtubule disruption.
    Samarakoon R; Higgins CE; Higgins SP; Higgins PJ
    Cell Signal; 2009 Jun; 21(6):986-95. PubMed ID: 19249354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
    Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
    Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The basic helix-loop-helix/leucine zipper transcription factor USF2 integrates serum-induced PAI-1 expression and keratinocyte growth.
    Qi L; Higgins CE; Higgins SP; Law BK; Simone TM; Higgins PJ
    J Cell Biochem; 2014 Oct; 115(10):1840-7. PubMed ID: 24905330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells.
    Guo B; Inoki K; Isono M; Mori H; Kanasaki K; Sugimoto T; Akiba S; Sato T; Yang B; Kikkawa R; Kashiwagi A; Haneda M; Koya D
    Kidney Int; 2005 Sep; 68(3):972-84. PubMed ID: 16105028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion.
    Kutz SM; Hordines J; McKeown-Longo PJ; Higgins PJ
    J Cell Sci; 2001 Nov; 114(Pt 21):3905-14. PubMed ID: 11719557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAI-1 mediates the TGF-beta1+EGF-induced "scatter" response in transformed human keratinocytes.
    Freytag J; Wilkins-Port CE; Higgins CE; Higgins SP; Samarakoon R; Higgins PJ
    J Invest Dermatol; 2010 Sep; 130(9):2179-90. PubMed ID: 20428185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.
    Jung ES; Lee J; Heo NJ; Kim S; Kim DK; Joo KW; Han JS
    Nephrology (Carlton); 2016 Jul; 21(7):574-82. PubMed ID: 26869361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascochlorin suppresses TGF-β1-induced PAI-1 expression through the inhibition of phospho-EGFR in rat kidney fibroblast cells.
    Cho HJ; Kang JH; Jeong JH; Jeong YJ; Park KK; Park YY; Moon YS; Kim HT; Chung IK; Kim CH; Chang HW; Chang YC
    Mol Biol Rep; 2012 Apr; 39(4):4597-603. PubMed ID: 21947785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.
    Wakahara K; Kobayashi H; Yagyu T; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    J Cell Biochem; 2004 Oct; 93(3):437-53. PubMed ID: 15372629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial monolayer wounding stimulates binding of USF-1 to an E-box motif in the plasminogen activator inhibitor type 1 gene.
    Providence KM; White LA; Tang J; Gonclaves J; Staiano-Coico L; Higgins PJ
    J Cell Sci; 2002 Oct; 115(Pt 19):3767-77. PubMed ID: 12235287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression.
    Takeda K; Ichiki T; Tokunou T; Iino N; Fujii S; Kitabatake A; Shimokawa H; Takeshita A
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):868-73. PubMed ID: 11348889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β1-p53 cooperativity regulates a profibrotic genomic program in the kidney: molecular mechanisms and clinical implications.
    Higgins CE; Tang J; Mian BM; Higgins SP; Gifford CC; Conti DJ; Meldrum KK; Samarakoon R; Higgins PJ
    FASEB J; 2019 Oct; 33(10):10596-10606. PubMed ID: 31284746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.